Clinical trial
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732 · University of North Carolina, Chapel Hill, Other · Completed
Key facts
| NCT number | NCT00407732 |
|---|---|
| Title | Overcoming Psychiatric Barriers to the Treatment of Hepatitis C |
| Official title | Overcoming Neuropsychiatric Barriers to the Treatment of Hepatitis C |
| Lead sponsor | University of North Carolina, Chapel Hill, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hepatitis C, Substance Use Disorders, Mental Disorder |
| Intervention type | Behavioral |
| Interventions | psychosocial intervention |
| Enrollment | 101 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2010 |
| Completion | Oct 1, 2011 |
| First posted | Dec 5, 2006 |
| Last update posted | Jan 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: